Page last updated: 2024-10-24

glucosyltransferase activity

Definition

Target type: molecularfunction

Catalysis of the transfer of a glucosyl group to an acceptor molecule, typically another carbohydrate or a lipid. [ISBN:0198506732]

Glucosyltransferases are a diverse group of enzymes that catalyze the transfer of a glucose moiety from a donor molecule, typically a sugar nucleotide, to an acceptor molecule. This process is essential for a wide range of biological functions, including:

1. **Glycoprotein synthesis:** Glucosyltransferases play a critical role in the biosynthesis of glycoproteins, which are proteins with covalently attached carbohydrate chains. These enzymes add glucose residues to specific amino acid residues in the protein backbone, leading to the formation of N-linked or O-linked glycans. These glycans contribute to the protein's folding, stability, and biological activity.

2. **Glycolipid synthesis:** Glucosyltransferases are also involved in the synthesis of glycolipids, which are lipids with attached carbohydrate chains. These enzymes add glucose residues to ceramide, a precursor molecule for sphingolipids, to form glucosylceramide, the starting point for the synthesis of complex glycosphingolipids.

3. **Polysaccharide synthesis:** Glucosyltransferases are crucial for the synthesis of various polysaccharides, including starch, glycogen, and cellulose. These enzymes transfer glucose residues from donor molecules to growing polysaccharide chains, contributing to the formation of complex carbohydrate structures.

4. **Bacterial virulence:** In some pathogenic bacteria, glucosyltransferases play a crucial role in virulence by modifying host cell surfaces. For example, glucosyltransferases can add glucose residues to host cell receptors, interfering with immune recognition and promoting bacterial adhesion and invasion.

5. **Drug metabolism:** Glucosyltransferases are involved in the metabolism of certain drugs, particularly those containing hydroxyl groups. These enzymes can add glucose residues to the drug molecules, altering their pharmacokinetic properties, such as absorption, distribution, metabolism, and excretion.

The mechanism of glucosyltransferase activity generally involves the following steps:

1. **Binding of the donor and acceptor molecules:** The enzyme binds the donor molecule, typically a sugar nucleotide like UDP-glucose, and the acceptor molecule, which can be a protein, lipid, or carbohydrate.

2. **Formation of a glucosyl-enzyme intermediate:** The enzyme catalyzes the transfer of the glucose moiety from the donor molecule to a specific amino acid residue in the enzyme's active site, forming a glucosyl-enzyme intermediate.

3. **Transfer of the glucose residue to the acceptor molecule:** The enzyme then transfers the glucose residue from the intermediate to the acceptor molecule, forming a new glycosidic bond.

4. **Release of the product:** The enzyme releases the product, which is the modified acceptor molecule, and the enzyme is ready to catalyze another reaction.

The specificity of glucosyltransferases is determined by their active site, which can recognize and bind specific donor and acceptor molecules. This specificity allows for the precise modification of carbohydrate structures and the regulation of diverse biological processes.'
"

Proteins (3)

ProteinDefinitionTaxonomy
Lysosomal acid glucosylceramidaseA lysosomal acid glucosylceramidase that is encoded in the genome of cow. [OMA:Q2KHZ8, PRO:DNx]Bos taurus (cattle)
Non-lysosomal glucosylceramidaseA non-lysosomal glucosylceramidase that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q9HCG7]Homo sapiens (human)
Lysosomal acid glucosylceramidaseA lysosomal acid glucosylceramidase that is encoded in the genome of human. [PRO:DNx, UniProtKB:P04062]Homo sapiens (human)

Compounds (47)

CompoundDefinitionClassesRoles
ambroxolAmbroxol: A metabolite of BROMHEXINE that stimulates mucociliary action and clears the air passages in the respiratory tract. It is usually administered as the hydrochloride.aromatic amine
beta-glucono-1,5-lactonebeta-glucono-1,5-lactone: structure

D-glucono-1,5-lactone : An aldono-1,5-lactone obtained from D-gluconic acid.
aldono-1,5-lactone;
gluconolactone
animal metabolite;
mouse metabolite
1-deoxynojirimycin1-deoxy-nojirimycin: structure in first source

duvoglustat : An optically active form of 2-(hydroxymethyl)piperidine-3,4,5-triol having 2R,3R,4R,5S-configuration.
2-(hydroxymethyl)piperidine-3,4,5-triol;
piperidine alkaloid
anti-HIV agent;
anti-obesity agent;
bacterial metabolite;
EC 3.2.1.20 (alpha-glucosidase) inhibitor;
hepatoprotective agent;
hypoglycemic agent;
plant metabolite
miglustatmiglustat : A hydroxypiperidine that is deoxynojirimycin in which the amino hydrogen is replaced by a butyl group.

miglustat: a glucosylceramide synthase inhibitor
piperidines;
tertiary amino compound
anti-HIV agent;
EC 2.4.1.80 (ceramide glucosyltransferase) inhibitor
castanosperminecastanospermine : A tetrahydroxyindolizidine alkaloid that consists of octahydroindolizine having four hydroxy substituents located at positions 1, 6, 7 and 8 (the 1S,6S,7R,8R,8aR-diastereomer).

castanospermine: indolizidine alkaloid from seeds of Australian legume, Castanospermum australe
indolizidine alkaloidanti-HIV-1 agent;
anti-inflammatory agent;
EC 3.2.1.* (glycosidase) inhibitor;
metabolite
n-phenylphthalimideN-phenylphthalimide: structure given in first source
fagominefagomine: structure in first sourcepiperidines
N-Benzylphthalimideisoindoles
1-(10h-phenothiazin-2-yl)ethanone1-(10H-phenothiazin-2-yl)ethanone: structure in first sourcephenothiazines
mor-14N-methyldeoxynojirimycin: glucosidase inhibitorhydroxypiperidine;
piperidine alkaloid;
tertiary amino compound
anti-HIV agent;
cardioprotective agent;
EC 3.2.1.20 (alpha-glucosidase) inhibitor;
plant metabolite
1,2,3,4-tetrahydroxy-nor-tropanecalystegine B(2): RN given for (2-endo,3-exo,4-endo)-isomer; structure in first source
2,5-dihydroxymethyl-3,4-dihydroxypyrrolidine2,5-dihydroxymethyl-3,4-dihydroxypyrrolidine: structure given in first sourcedihydroxypyrrolidine
homonojirimycinhomonojirimycin: inhibits alpha-glucosidase; RN given for (2R-(2alpha,3alpha,4beta,5alpha,6beta))-isomer; structure in first source
cyclophellitolcyclophellitol: structure given in first source; isolated from Phellinus sp.
migalastatmigalastat: a potent inhibitor of glycolipid biosynthesispiperidines
calystegine a3calystegine A3: also inhibits beta-xylosidase; structure in first source
miglitolpiperidines
isofagominepiperidines
1,4-dideoxy-1,4-imino-d-arabinitol
n-nonyl-1-deoxynojirimycinN-nonyldeoxynojirimycin : A hydroxypiperidine that is deoxynojirimycin (duvoglustat) in which the amino hydrogen is replaced by a nonyl group.hydroxypiperidine;
tertiary amino compound
antiviral agent;
EC 3.2.1.20 (alpha-glucosidase) inhibitor;
EC 3.2.1.45 (glucosylceramidase) inhibitor
1-(1-benzimidazolyl)-3-(1-cyclohex-3-enylmethoxy)-2-propanolbenzimidazoles
2-(2-phenylethylthio)-3-pyridinecarboxylic acidaromatic carboxylic acid;
pyridines
4-(2-furanylmethyl)-3-(phenylmethyl)-1H-1,2,4-triazole-5-thionebenzenes
2-[[4-(4-chloroanilino)-6-(1-pyrrolidinyl)-1,3,5-triazin-2-yl]amino]ethanoldialkylarylamine;
tertiary amino compound
4-(benzenesulfonamido)-N-(5-ethyl-1,3,4-thiadiazol-2-yl)benzamidesulfonamide
tamoxifenstilbenoid;
tertiary amino compound
angiogenesis inhibitor;
antineoplastic agent;
bone density conservation agent;
EC 1.2.3.1 (aldehyde oxidase) inhibitor;
EC 2.7.11.13 (protein kinase C) inhibitor;
estrogen antagonist;
estrogen receptor antagonist;
estrogen receptor modulator
4-oxido-3-(4-phenoxyphenyl)-4a,5,6,7,8,8a-hexahydroquinoxalin-1-ium 1-oxidearomatic ether
2-[[4-(3-methylanilino)-6-(1-pyrrolidinyl)-1,3,5-triazin-2-yl]amino]ethanoldialkylarylamine;
tertiary amino compound
N-(1-benzylpiperidin-4-yl)-2-(pyridin-3-yl)quinazolin-4-amineN-(1-benzylpiperidin-4-yl)-2-(pyridin-3-yl)quinazolin-4-amine : A member of the class of quinazolines that is quinazoline which is substituted by a pyridin-3-yl group and a (1-benzylpiperidin-4-yl)nitrilo group at positions 2 and 4, respectively.aromatic amine;
piperidines;
pyridines;
quinazolines;
secondary amino compound;
tertiary amino compound
N-[4-methyl-2-(4-morpholinyl)-6-quinolinyl]cyclohexanecarboxamideaminoquinoline
n-(5-adamantane-1-yl-methoxy-pentyl)deoxynojirimycin
ogt2378sinbaglustat: an antineopl agent; structure in first source
nnc 26-9100NNC 26-9100: structure in first sourceaminopyridine
3-epi-fagomine3-epi-fagomine : A member of the class of hydroxypiperidines that is piperidine carrying a hydroxymethyl substituent at position 2 as well as two hydroxy substituents at positions 3 and 4 (the 2R,3R,4S-diastereomer).amino monosaccharide;
hydroxypiperidine;
primary alcohol;
secondary alcohol;
secondary amino compound;
triol
EC 3.2.1.10 (oligo-1,6-glucosidase) inhibitor;
EC 3.2.1.23 (beta-galactosidase) inhibitor;
plant metabolite
l-altro-1-deoxynojirimycinL-altro-1-deoxynojirimycin: structure in first source
2-[[4-[2-[(2-methylpropan-2-yl)oxy]anilino]-6-(1-pyrrolidinyl)-1,3,5-triazin-2-yl]amino]ethanolaromatic ether
2-[[4-(5-chloro-2-methoxyanilino)-6-(1-piperidinyl)-1,3,5-triazin-2-yl]amino]ethanolmethoxybenzenes;
substituted aniline
2-[[4-(4-methylanilino)-6-(1-pyrrolidinyl)-1,3,5-triazin-2-yl]amino]ethanoldialkylarylamine;
tertiary amino compound
2-[[4-(2-chloroanilino)-6-(1-pyrrolidinyl)-1,3,5-triazin-2-yl]amino]ethanoldialkylarylamine;
tertiary amino compound
2-[[4-(2-methoxyanilino)-6-(1-pyrrolidinyl)-1,3,5-triazin-2-yl]amino]ethanolmethoxybenzenes;
substituted aniline
2-[[4-(3-methoxyanilino)-6-(1-pyrrolidinyl)-1,3,5-triazin-2-yl]amino]ethanolmethoxybenzenes;
substituted aniline
2-[[4-(4-methoxyanilino)-6-(1-pyrrolidinyl)-1,3,5-triazin-2-yl]amino]ethanolmethoxybenzenes;
substituted aniline
2-[[4-(2-hydroxyethylamino)-6-(1-pyrrolidinyl)-1,3,5-triazin-2-yl]amino]phenoldialkylarylamine;
tertiary amino compound
2-[[4-(2-phenoxyanilino)-6-(1-pyrrolidinyl)-1,3,5-triazin-2-yl]amino]ethanolaromatic ether
2-[[4-(1-pyrrolidinyl)-6-[2-(trifluoromethoxy)anilino]-1,3,5-triazin-2-yl]amino]ethanolaromatic ether
2-[[4-(5-chloro-2-ethoxyanilino)-6-(1-pyrrolidinyl)-1,3,5-triazin-2-yl]amino]ethanolaromatic ether
2-[[4-(5-chloro-2-propan-2-yloxyanilino)-6-(1-pyrrolidinyl)-1,3,5-triazin-2-yl]amino]ethanolaromatic ether